Jazz Pharmaceuticals
JAZZ
#1410
Rank
HK$115.84 B
Marketcap
HK$1,805
Share price
-2.62%
Change (1 day)
31.64%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): HK$28.22

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$28.45. In 2025 the company made an earnings per share (EPS) of -HK$45.38 a decrease over its 2024 EPS that were of HK$71.41.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$28.22-162.17%
2025-HK$45.38-163.56%
2024HK$71.4139.08%
2023HK$51.34-285.03%
2022-HK$27.75-34.2%
2021-HK$42.17-224.83%
2020HK$33.78-53.25%
2019HK$72.2723.59%
2018HK$58.47-8.24%
2017HK$63.7223.74%
2016HK$51.5022.12%
2015HK$42.17478.49%
2014HK$7.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.15 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
HK$64.98 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-HK$8.39-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$3.53-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel